Notes on the Complement System: Alternative Pathway Regulation, MAC Formation, and Macrophage Interactions

Complement Pathways: Alternative Pathway Regulation, MAC, and Macrophage Interactions

  • Overview of the alternative pathway

    • The alternative pathway is described as effective and potent, but inherently non-specific because it can be initiated simply by water-driven cleavages. This reflects its role in innate immunity: rapid, broad, frontline defense.
    • The innate nature means there must be safeguards to protect host cells from unintended complement activation.

  • Complement control proteins: two functional groups

    • Function: regulate C3b (the key opsonizing molecule in the pathway).
    • Two groups exist:
    • Positive regulators (stabilize/accelerate complement activation and opsonization on pathogens).
    • Negative regulators (dampen or terminate activation on host cells to prevent self-damage).
    • Four regulatory approaches highlighted:
    • Positive regulation: stabilize the C3 convertase on pathogen surfaces to enhance activation and opsonization. This is called properdin (also spelled proparadin in the transcript).
    • Negative regulation on pathogen surfaces: degrade or inactivate C3b to prevent unwarranted amplification.
    • Surface protection on host cells: prevent complement fixation on human cell surfaces.
    • Prevention of exhaustion of C3 in circulation by modulating activation levels.

  • Positive regulator: Properdin (proparadin)

    • Mechanism: after a C3 convertase has formed on a pathogen surface, properdin binds and stabilizes it, preventing Bb from dissociating and thereby maintaining convertase activity.
    • Result: increased stability, duration, and efficiency of C3 convertase activity and subsequent opsonization.
    • Notation in the pathway: stabilizes the C3 convertase complex on microbial surfaces (often denoted as C3bBbP when stabilized by properdin).

  • Negative regulation: factors H and I on pathogen surfaces

    • Factor H and Factor I act to inactivate C3b after it has already been deposited and begun opsonization.
    • Process: Factor H binds to C3b and recruits Factor I, which cleaves C3b into inactive fragments, destroying the head structure of the “pushpin” (C3b) and preventing the formation or activity of C3 convertase.
    • Result: limited opsonization, reduced phagocytosis drive, and conservation of C3 (avoiding depletion).
    • Consequence: this slows complement fixation on non-pathogenic surfaces and helps prevent unnecessary consumption of C3.

  • Cell-surface regulators: DAF and MCP

    • These regulators are membrane-associated and act on human cell surfaces to prevent unintended complement activation.
    • Decay-accelerating factor (DAF, also known as CD55): disrupts C3 convertases (both on pathogen and host surfaces when mislocalized), preventing sustained activity.
    • Membrane Cofactor Protein (MCP, CD46): serves as a cofactor for Factor I to cleave C3b on host cell surfaces, helping to inactivate the convertase and inactivate C3b.
    • Key distinction: DAF mainly disrupts the convertase; MCP provides a cofactor for proteolytic inactivation by Factor I.
    • On pathogens or plasma proteins, these regulators are not present, so complement can proceed unimpeded on pathogens but is curtailed on host cells.

  • The three panels distinction: pathogen surface vs. human cell surface

    • Pathogen surface: complement activation proceeds with assistance from positive regulators (properdin) to stabilize convertases and promote opsonization.
    • Human cell surface: protective regulators (DAF, MCP) act to prevent unintended activation and promote inactivation of C3b, preserving self-tissue.
    • In the context of the pathogen surface, if there is failure of regulation, the complement cascade can proceed to effector functions like MAC formation.

  • MAC formation and regulation (membrane attack complex)

    • The MAC is a pore-forming structure that directly lyses pathogens; it is the terminal effector of the alternative and other pathways.
    • Core components: C5b, C6, C7, C8, C9 (C5b-9).
    • Initiation of MAC assembly:
    • C5b binds C6 and C7. The C5b67 complex associates with the membrane via C7.
    • In the polymerization stage, C8 binds and inserts into the membrane.
    • C9 molecules polymerize to form a pore through the lipid bilayer; the pore disrupts osmotic balance and lyses the cell.
    • Role of C5a and C3a as inflammatory mediators (anaphylatoxins)
    • C5a is a potent inflammatory mediator, more powerful than C3a, and can drive inflammation to a high magnitude.
    • C3a is also an anaphylatoxin but generally less potent than C5a.
    • Regulation on host cells prevents host MAC formation
    • HRF (homologous restriction factor) or other regulators limit MAC to host cells.
    • CD59 (Protectin) directly inhibits MAC formation on human cells by blocking C9 polymerization.
    • Defects in protective regulators (e.g., CD55/DAF, CD46/MCP, CD59) predispose to self-attack by MAC on host cells.
    • Clinical relevance: Neisseria species (e.g., Neisseria meningitidis) are encapsulated bacteria that rely on complement to be cleared.
    • Encapsulation cloaks bacteria from immune recognition, increasing the need for complement-mediated opsonization and MAC attack for clearance.
    • Defects in complement components (C3, C5, C6–C9) increase susceptibility to meningitis from encapsulated bacteria.
    • A notable statistic: deficiency in C9 is relatively prevalent in some populations (reported as about 1 in 40 individuals in the Japanese population).
    • Pathology of MAC and self-protection disorders
    • The lack of MAC specificity necessitates control proteins to prevent host cell damage.
    • Paroxysmal nocturnal hemoglobinuria (PNH) illustrates the consequence when host cell protective regulators are absent/defective: red blood cells lack GPI-anchored regulators (such as DAF/CD55 and CD59/Protectin) and are susceptible to MAC-mediated lysis; symptoms often worsen at night.
    • Terminology note: while some sources refer to the complete complex as MAC, the correct concept is the MAC formed by the assembly of C5b-9; the components C5, C6, C7, C8, and C9 participate in the complex.
    • Visualizations and animations
    • Schematics show initiation with C5b binding C6 and C7, followed by C8 and C9 polymerization to form a perforating complex.
    • Animations emphasize the pore-forming step and illustrate how polymerized C9 creates a donut-like pore in the pathogen membrane.

  • Inflammation and inflammatory mediators in complement activation

    • Small peptide fragments C3a and C5a promote inflammatory responses; they must be kept in check to avoid excessive systemic inflammation.
    • C5a functions as a chemoattractant:
    • Attracts neutrophils and monocytes toward the site of complement activation.
    • Promotes adherence of these cells to the endothelium, enabling extravasation into tissues.
    • Upregulates phagocytic receptor expression on macrophages (notably CR1 and CR3), enhancing phagocytosis.
    • Diaphragm of C3a and C5a in tissue responses:
    • Induces smooth muscle contraction (contributes to gut motility and bronchiolar constriction) and can influence airway caliber.
    • Triggers degranulation of mast cells and basophils, releasing histamine and other vasoactive mediators.
    • Increases vascular permeability by loosening tight junctions between endothelial cells, promoting edema and immune cell extravasation.
    • Potentially dangerous outcomes: excessive C5a and C3a can contribute to anaphylaxis (systemic inflammatory response) if not properly regulated.

  • Macrophages and complement receptors: CR1-CR4

    • Macrophages originate from circulating monocytes that migrate into tissues and mature into long-lived phagocytes.
    • Macrophages live longer than neutrophils and can replenish lysosomes and enzymes to sustain phagocytosis repeatedly.
    • Role of opsonization in macrophage efficiency:
    • Complement-coated pathogens are recognized by macrophages via complement receptors, enhancing phagocytosis.
    • Without complement, macrophages can still phagocytose pathogens, but the process is less efficient; with complement coating it is more rapid and robust.
    • Adaptive immunity later enhances this further through antibody-mediated opsonization.
    • Maturation and tissue distribution:
    • Monocytes can leave the bloodstream and mature to macrophages in tissues.
    • They can also populate specific immune sites like lymph nodes and spleen; immature macrophages in the spleen form the white pulp, while those in the liver become Kupffer cells.
    • Kupffer cells are specialized liver macrophages that clear old red blood cells and other circulatory debris; they do not mount the same immune response as white-pulp macrophages but filter circulating blood.
    • Complement receptors on macrophages:
    • CR1 (CD35) is the most abundant macrophage receptor for C3b and is the most efficient at triggering phagocytosis by recognizing full C3b ligand.
    • CR3 (CD11b/CD18) and CR4 recognize cleaved fragments such as iC3b and related fragments that result from C3b processing; these receptors still promote phagocytosis but with different ligand affinities.
    • Visual concept of phagocytosis with opsonization
    • A macrophage encounters opsonized bacteria with C3b on its surface.
    • The macrophage’s CR1 binds C3b, triggering actin rearrangements to engulf the bacterium into a phagosome.
    • The phagosome then fuses with a lysosome to form a phagolysosome, where lysosomal enzymes and an acidic environment destroy the ingested microbe.

  • C3 and C5 convertases, and the downstream effector steps

    • C3 convertase (alternative pathway): $C3bBb$
    • Stabilized by properdin to form $C3bBbP$.
    • C5 convertase (alternative pathway): $C3bBbC3b$ (the complex that cleaves C5 to C5a and C5b)
    • C5a and C3a as inflammatory mediators (revisited): promote inflammation; C5a is more potent and can drive strong inflammatory responses if unregulated.
    • Initiation and polymerization of MAC: the MAC requires C5b to recruit C6, C7, C8, and multiple C9 molecules to create a pore.
    • The pathogen surface vs. host surface distinction continues to be critical throughout these steps due to host regulators.

  • Clinical and real-world relevance

    • Encapsulated bacteria and complement dependence: encapsulation by bacteria like Neisseria meningitidis requires complement for effective clearance; loss of complement function increases risk of meningitis.
    • Inherited deficiencies and susceptibility: deficiencies in one or more complement components (C3, C5, C6–C9) significantly raise susceptibility to meningitis from encapsulated bacteria.
    • Population genetics insight: deficiency in C9 has a relatively high reported prevalence in some populations (e.g., roughly 1 in 40 in a Japanese population sample), highlighting variable genetic susceptibility to MAC-mediated defense.
    • Paroxysmal nocturnal hemoglobinuria (PNH): a disorder where red blood cells lack protective surface regulators (e.g., DAF/CD55, CD59/Protectin) due to a GPI-anchor deficiency; this allows MAC to form on host red blood cells, causing intravascular hemolysis that tends to worsen at night and can lead to hypoxemia and breathlessness.

  • Summary of key components and their labels

    • Positive regulator: Properdin, stabilizes C3 convertase on pathogens (often noted as $C3bBbP$).
    • Negative regulators on host surfaces: Factor H, Factor I inactivate C3b; DAF (CD55) disrupts convertases; MCP (CD46) serves as a cofactor for Factor I to cleave C3b.
    • Membrane regulators to block MAC on host cells: CD59 (Protectin); HRF (Homologous Restriction Factor).
    • Opsonization and phagocytosis: CR1 (CD35) binds full C3b; CR3 (CD11b/CD18) and CR4 recognize cleaved fragments (e.g., iC3b) to promote phagocytosis.
    • Anaphylatoxins and inflammation: C3a and C5a promote inflammation; C5a is a strong chemoattractant and enhancer of phagocytosis via receptor upregulation.
    • MAC components and function: MAC = C5b–C9; initiates membrane perforation leading to lysis of susceptible pathogens; requires tight regulation to avoid host tissue damage.

  • A few conceptual takeaways

    • The complement system is potent but needs precise regulation to avoid host tissue damage while still targeting pathogens effectively.
    • Innate immune responses (complement) interface with adaptive immunity: opsonization by C3b enhances phagocytosis; antibodies provide even stronger, more specific opsonization later.
    • The liver produces many soluble plasma complement proteins, while cell-surface regulators (DAF, MCP, CD59) are embedded in host cell membranes to provide localized protection.
    • Understanding MAC formation helps explain both rapid defense against encapsulated bacteria and the pathology of diseases like PNH when protection is missing.

  • Quick references to pathway equations (for study notes)

    • C3 convertase in the alternative pathway: extC3convertase=extC3bBbext{C3 convertase} = ext{C3bBb}
    • Stabilized convertase by properdin: extC3bBbPext{C3bBbP}
    • C5 convertase (alternative pathway): extC5convertase=extC3bBbC3bext{C5 convertase} = ext{C3bBbC3b}
    • MAC components: extMAC=extC5b−9ext{MAC} = ext{C5b-9}, assembled as C5b engages C6, C7, C8, and multiple C9 units to form a pore.
    • Anaphylatoxins: extC3a,extC5aext{C3a}, ext{C5a} (with C5a being the more potent inflammatory mediator at many sites).